← Evidence map

ArticleLeukemia2015

NFATc1 as a therapeutic target in FLT3-ITD-positive AML.

S K Metzelder et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25976987